INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 231 filers reported holding INOVIO PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.28 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $117,000 | +50.0% | 10,091 | -3.5% | 0.01% | +9.1% |
| Q1 2020 | $78,000 | +16.4% | 10,460 | -42.1% | 0.01% | 0.0% |
| Q1 2019 | $67,000 | -8.2% | 18,056 | -1.2% | 0.01% | -21.4% |
| Q4 2018 | $73,000 | -18.9% | 18,273 | +12.3% | 0.01% | -26.3% |
| Q3 2018 | $90,000 | +52.5% | 16,273 | +7.2% | 0.02% | +26.7% |
| Q2 2018 | $59,000 | -18.1% | 15,173 | -7.0% | 0.02% | -21.1% |
| Q1 2018 | $72,000 | +2.9% | 16,323 | +0.7% | 0.02% | 0.0% |
| Q4 2017 | $70,000 | +204.3% | 16,215 | +353.2% | 0.02% | +90.0% |
| Q3 2017 | $23,000 | +21.1% | 3,578 | 0.0% | 0.01% | +11.1% |
| Q2 2017 | $19,000 | -5.0% | 3,578 | +8.7% | 0.01% | -30.8% |
| Q1 2017 | $20,000 | +185.7% | 3,292 | +229.2% | 0.01% | +160.0% |
| Q4 2016 | $7,000 | – | 1,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Green Alpha Advisors, LLC | 570,049 | $221,749 | 0.17% |
| GMT CAPITAL CORP | 1,513,500 | $588,752 | 0.02% |
| Cedar Brook Financial Partners, LLC | 130,522 | $50,773 | 0.01% |
| Arlington Capital Management, Inc. | 27,735 | $10,789 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 296,948 | $116 | 0.01% |
| Keystone Financial Group | 109,897 | $42,751 | 0.01% |
| Hennion & Walsh Asset Management, Inc. | 163,562 | $63,626 | 0.00% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 1,149,974 | $447,340 | 0.00% |
| Freedom Investment Management, Inc. | 62,298 | $24,234 | 0.00% |
| Renaissance Technologies | 4,889,500 | $1,902 | 0.00% |